Immune Therapeutics Dividends

IMUN -  USA Stock  

USD 2.30  0.60  20.69%

Immune Therapeutics' past performance could be the main factor of why investors trade Immune Therapeutics stock today. Investors should clearly understand every aspect of the Immune Therapeutics dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Immune Therapeutics' past dividend schedule and payout information as well as to compare it to related equities in the form of a graph and calendar. Immune Therapeutics dividends can also provide a clue to the current valuation of Immune Therapeutics.

Immune Dividends 

 
Refresh
Investing in stocks that pay dividends, such as otc stock of Immune Therapeutics, is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Immune Therapeutics must own a stock before its ex-dividend date to receive its next dividend.
Use comma (,) to separate each symbol. If not specified, the peers will be provided automatically based on Macroaxis sector classification standards for immune therapeutics. To filter out specific equities, please toggle its corresponding legend item. Please see Risk vs Return Analysis.

Specify up to 10 symbols:

The market value of Immune Therapeutics is measured differently than its book value, which is the value of Immune that is recorded on the company's balance sheet. Investors also form their own opinion of Immune Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Immune Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immune Therapeutics' market value can be influenced by many factors that don't directly affect Immune Therapeutics underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immune Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Immune Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immune Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Your potential positions

Your current and potential positions are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification; find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

My Equities

My Current Equities and Potential Positions

IMUN - USA OTC Stock
Immune Therapeutics
IMUN
Business Address2431 Aloma Avenue
ExchangeOTC Exchange
USD 2.3
Please see Risk vs Return Analysis. Note that the Immune Therapeutics information on this page should be used as a complementary analysis to other Immune Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Immune OTC Stock analysis

When running Immune Therapeutics price analysis, check to measure Immune Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immune Therapeutics is operating at the current time. Most of Immune Therapeutics' value examination focuses on studying past and present price action to predict the probability of Immune Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immune Therapeutics' price. Additionally, you may evaluate how the addition of Immune Therapeutics to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go